Page 2

  • A picture of dermatologist examining patient skin moles with a dermoscope at a health clinic.
    Image attribution tooltip
    LordHenriVoton, E+ via Getty Images
    Image attribution tooltip

    Cancer test maker Dermtech to cut 100 jobs, explore strategic options

    Dermtech, which will not hold a first-quarter earnings call, said the layoffs are part of a broader effort to “significantly reduce” expenses.

    M&A
  • Scientific illustration of a migrating breast cancer cell
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    FDA approves Lumicell’s breast cancer imaging tool

    Lumicell developed the technology to enable physicians to detect residual cancer in the breast cavity after surgery.

  • Intuitive Surgical's da Vinci 5 robotic system.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip

    Intuitive’s rollout of new da Vinci 5 robot steals Q1 spotlight

    While Intuitive has already placed eight new surgical robots, executives cautioned system placements could be choppy in the coming months.

  • A view of Baxter International's production facility in the state of North-Rhine Wetsphalia on January 15, 2021 in Halle, Germany.
    Image attribution tooltip
    Sascha Schuermann via Getty Images
    Image attribution tooltip

    Spinoffs, sales and tuck-ins top medtech deal priorities: Moody’s

    After J&J’s $13.1 billion purchase of Shockwave Medical, Moody’s analysts see the potential for other larger pick-ups “if interest rates substantially decrease.”

  • A picture of a computer screen with Scopio Labs' bone marrow analysis software on it.
    Image attribution tooltip
    Permission granted by Scopio Labs
    Image attribution tooltip

    Scopio Labs wins de novo nod for bone marrow analysis software

    Scopio can now add the application to its imaging platforms that allow users to view blood samples digitally rather than under a microscope.

  • Blocks spell M and A
    Image attribution tooltip
    Nastassia Samal via Getty Images
    Image attribution tooltip

    Bruker to acquire Nanostring for $393M

    Bruker made an offer roughly two months after Nanostring filed for bankruptcy protection and said it may restructure.

    M&A
  • Anne Wojcicki speaking event
    Image attribution tooltip
    Brad Barket via Getty Images
    Image attribution tooltip

    23andMe CEO plans to take company private

    Anne Wojcicki wants to buy all outstanding shares of the DNA testing firm, which has seen its stock slump in recent years.

  • Aerial view of a sprawling Boston Scientific manufacturing plant
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific recalls blood-blocking agent linked to 2 deaths

    Seven injuries and 11 incidents were also associated with the safety issue.

  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    ‘An incredible undertaking’: 5 takeaways from Philips consent decree

    Under the agreement, the FDA will use rare powers to require repairs, replacements or refunds for recalled respiratory machines.

    Updated April 17, 2024
  • Abbott company sign outside
    Image attribution tooltip

    Courtesy of Abbott Laboratories

    Image attribution tooltip

    Abbott looks to ‘highly productive’ device pipeline for future growth

    CEO Robert Ford highlighted new and upcoming products throughout the earnings call, calling the recently approved Triclip valve a “billion-dollar opportunity."

  • A white sign with the word Lilly written in red stands outside of an office.
    Image attribution tooltip
    Scott Olson via Getty Images
    Image attribution tooltip

    Lilly obesity drug shows benefit in sleep disorder study, pointing to new use

    Positive data for Lilly’s medicine tirzepatide in sleep apnea are the latest signal the benefits of GLP-1 agonists could extend beyond diabetes and weight loss.